These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA. Nature; 2008 Dec 11; 456(7223):809-13. PubMed ID: 18997771 [Abstract] [Full Text] [Related]
4. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G. Cancer Res; 2003 Jun 15; 63(12):3403-12. PubMed ID: 12810677 [Abstract] [Full Text] [Related]
5. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Yamagishi S, Yonekura H, Yamamoto Y, Fujimori H, Sakurai S, Tanaka N, Yamamoto H. Lab Invest; 1999 Apr 15; 79(4):501-9. PubMed ID: 10212003 [Abstract] [Full Text] [Related]
6. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. Hsu S, Huang F, Friedman E. J Cell Physiol; 1995 Nov 15; 165(2):239-45. PubMed ID: 7593201 [Abstract] [Full Text] [Related]
7. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M. Am J Pathol; 2003 Jun 15; 162(6):1913-26. PubMed ID: 12759248 [Abstract] [Full Text] [Related]
8. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Yokota T, Ma RC, Park JY, Isshiki K, Sotiropoulos KB, Rauniyar RK, Bornfeldt KE, King GL. Diabetes; 2003 Mar 15; 52(3):838-45. PubMed ID: 12606528 [Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY. Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444 [Abstract] [Full Text] [Related]
10. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. Abramsson A, Lindblom P, Betsholtz C. J Clin Invest; 2003 Oct 01; 112(8):1142-51. PubMed ID: 14561699 [Abstract] [Full Text] [Related]
11. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT. Am J Pathol; 2006 Jun 01; 168(6):2036-53. PubMed ID: 16723717 [Abstract] [Full Text] [Related]
12. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. Reddy K, Zhou Z, Jia SF, Lee TH, Morales-Arias J, Cao Y, Kleinerman ES. Int J Cancer; 2008 Aug 15; 123(4):831-7. PubMed ID: 18537159 [Abstract] [Full Text] [Related]
13. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer. Suzuki S, Dobashi Y, Hatakeyama Y, Tajiri R, Fujimura T, Heldin CH, Ooi A. BMC Cancer; 2010 Nov 30; 10():659. PubMed ID: 21118571 [Abstract] [Full Text] [Related]
14. Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis. Song N, Huang Y, Shi H, Yuan S, Ding Y, Song X, Fu Y, Luo Y. Cancer Res; 2009 Aug 01; 69(15):6057-64. PubMed ID: 19584297 [Abstract] [Full Text] [Related]
15. Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro. Siedlecki J, Wertheimer C, Wolf A, Liegl R, Priglinger C, Priglinger S, Eibl-Lindner K. Graefes Arch Clin Exp Ophthalmol; 2017 May 01; 255(5):963-972. PubMed ID: 28161830 [Abstract] [Full Text] [Related]
16. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Benjamin LE, Hemo I, Keshet E. Development; 1998 May 01; 125(9):1591-8. PubMed ID: 9521897 [Abstract] [Full Text] [Related]
17. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. Hasumi Y, Kłosowska-Wardega A, Furuhashi M, Ostman A, Heldin CH, Hellberg C. Int J Cancer; 2007 Dec 15; 121(12):2606-14. PubMed ID: 17691110 [Abstract] [Full Text] [Related]
18. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F. Cancer Res; 2000 Apr 15; 60(8):2178-89. PubMed ID: 10786682 [Abstract] [Full Text] [Related]
19. Effects of angiogenic growth factor combinations on retinal endothelial cells. Castellon R, Hamdi HK, Sacerio I, Aoki AM, Kenney MC, Ljubimov AV. Exp Eye Res; 2002 Apr 15; 74(4):523-35. PubMed ID: 12076096 [Abstract] [Full Text] [Related]
20. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. Cao R, Bråkenhielm E, Li X, Pietras K, Widenfalk J, Ostman A, Eriksson U, Cao Y. FASEB J; 2002 Oct 15; 16(12):1575-83. PubMed ID: 12374780 [Abstract] [Full Text] [Related] Page: [Next] [New Search]